Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy

Benitec Biopharma Debt to Equity Ratio 2014-2017 | BNTC

Current and historical debt to equity ratio values for Benitec Biopharma (BNTC) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Benitec Biopharma debt/equity for the three months ending September 30, 2017 was 0.00.
Benitec Biopharma Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2017-09-30 $0.00B $0.02B 0.00
2016-09-30 $0.00B $0.02B 0.00
2016-06-30 $0.00B $0.01B 0.00
2016-03-31 $0.00B $0.02B 0.00
2015-12-31 $0.00B $0.02B 0.00
2015-06-30 $0.00B $0.02B 0.00
2014-12-31 $0.00B $0.03B 0.00
2014-06-30 $0.00B $0.03B 0.00
2013-06-30 $0.00B $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.016B $0.004B
Benitec Biopharma Limited is a biotechnology company which developed a patented gene silencing technology delivered by gene therapy called DNA directed RNA interference. The company is developing ddRNAi-based therapeutics for chronic and life-threatening human conditions including hepatitis C and B, drug resistant lung cancer and wet age-related macular degeneration. Benitec Biopharma Limited is based in Sydney, Australia.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $128.706B 14.55
Gilead Sciences (GILD) United States $88.678B 10.68
Biogen (BIIB) United States $68.295B 13.83
Celgene (CELG) United States $60.136B 11.67
Vertex Pharmaceuticals (VRTX) United States $49.548B 86.55
Illumina (ILMN) United States $44.632B 51.99
Regeneron Pharmaceuticals (REGN) United States $43.798B 22.19
Alexion Pharmaceuticals (ALXN) United States $25.498B 17.45
BioMarin Pharmaceutical (BMRN) United States $17.033B 0.00
Incyte (INCY) United States $16.456B 454.88
Seattle Genetics (SGEN) United States $11.330B 0.00
Exact Sciences (EXAS) United States $9.349B 0.00
QIAGEN (QGEN) Netherlands $8.374B 26.78
Alnylam Pharmaceuticals (ALNY) United States $8.161B 0.00
BeiGene (BGNE) Cayman Islands $8.097B 0.00
Sarepta Therapeutics (SRPT) United States $8.038B 0.00
Bluebird Bio (BLUE) United States $6.842B 0.00
Exelixis (EXEL) United States $6.611B 18.74
Bio-Techne Corp (TECH) United States $6.081B 41.07
Amarin (AMRN) Ireland $5.657B 0.00
Galapagos (GLPG) Belgium $5.312B 0.00
Alkermes (ALKS) Ireland $5.135B 3305.00
Moderna (MRNA) United States $5.118B 0.00
Horizon Pharma Public (HZNP) Ireland $3.674B 15.12
MorphoSys AG Unsponsored ADR (MOR) Germany $3.674B 0.00
Array BioPharma (ARRY) United States $3.626B 0.00
Guardant Health (GH) United States $3.482B 0.00
ARGENX SE-ADR (ARGX) Netherlands $3.429B 0.00
Allogene Therapeutics (ALLO) United States $3.375B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.290B 0.00
Emergent Biosolutions (EBS) United States $3.099B 26.11
Ascendis Pharma (ASND) Denmark $3.096B 0.00
Blueprint Medicines (BPMC) United States $2.926B 0.00
China Biologic Products (CBPO) China $2.665B 18.97
Akcea Therapeutics (AKCA) United States $2.617B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.587B 0.00
Genomic Health (GHDX) United States $2.565B 86.58
ACADIA Pharmaceuticals (ACAD) United States $2.542B 0.00
Immunomedics (IMMU) United States $2.525B 0.00
Global Blood Therapeutics (GBT) United States $2.498B 0.00
Repligen (RGEN) United States $2.419B 75.55
Ligand Pharmaceuticals (LGND) United States $2.400B 18.36
Halozyme Therapeutics (HALO) United States $2.300B 51.32
Reata Pharmaceuticals (RETA) United States $2.230B 0.00
Amicus Therapeutics (FOLD) United States $2.217B 0.00
Arena Pharmaceuticals (ARNA) United States $2.176B 0.00
Myriad Genetics (MYGN) United States $2.160B 21.40
Mirati Therapeutics (MRTX) United States $2.080B 0.00
Denali Therapeutics (DNLI) United States $2.059B 0.00
Innoviva (INVA) United States $1.973B 11.16
AnaptysBio (ANAB) United States $1.900B 0.00
Acceleron Pharma (XLRN) United States $1.877B 0.00
Insmed (INSM) United States $1.791B 0.00
MyoKardia (MYOK) United States $1.788B 0.00
Allakos (ALLK) United States $1.733B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $1.717B 0.00
Spark Therapeutics (ONCE) United States $1.635B 0.00
Atara Biotherapeutics (ATRA) United States $1.618B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.575B 125.13
REGENXBIO (RGNX) United States $1.570B 21.06
Zai Lab Unsponsored ADR (ZLAB) China $1.493B 0.00
NeoGenomics (NEO) United States $1.473B 121.23
Medicines (MDCO) United States $1.456B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $1.446B 0.00
Cambrex (CBM) United States $1.435B 10.72
Aimmune Therapeutics (AIMT) United States $1.289B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.279B 0.00
Myovant Sciences (MYOV) United Kingdom $1.232B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.219B 0.00
WAVE Life Sciences (WVE) Singapore $1.202B 0.00
Clovis Oncology (CLVS) United States $1.194B 0.00
UniQure (QURE) Netherlands $1.161B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.147B 0.00
Rubius Therapeutics (RUBY) United States $1.132B 0.00
Sangamo Therapeutics (SGMO) United States $1.130B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.111B 0.00
ORCHARD THERAPT (ORTX) United Kingdom $1.084B 0.00
Lion Biotechnologies (IOVA) United States $1.081B 0.00
Rhythm Pharmaceuticals (RYTM) United States $1.031B 0.00
Audentes Therapeutics (BOLD) United States $1.023B 0.00
Editas Medicine (EDIT) United States $1.002B 0.00
Deciphera Pharmaceuticals (DCPH) United States $0.993B 0.00
Fate Therapeutics (FATE) United States $0.960B 0.00
Solid Biosciences (SLDB) United States $0.907B 0.00
Puma Biotechnology (PBYI) United States $0.903B 0.00
Retrophin (RTRX) United States $0.892B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.865B 0.00
InflaRx (IFRX) Germany $0.820B 0.00
Coherus BioSciences (CHRS) United States $0.796B 0.00
Athenex (ATNX) United States $0.775B 0.00
Novavax (NVAX) United States $0.773B 0.00
Principia Biopharma (PRNB) United States $0.767B 0.00
Acorda Therapeutics (ACOR) United States $0.758B 9.60
Apellis Pharmaceuticals (APLS) United States $0.756B 0.00
Vericel (VCEL) United States $0.750B 0.00
Heska (HSKA) United States $0.739B 60.49
UROGEN PHARMA (URGN) Israel $0.738B 0.00
Dynavax Technologies (DVAX) United States $0.730B 0.00
G1 THERAPEUTICS (GTHX) United States $0.728B 0.00
CytomX Therapeutics (CTMX) United States $0.725B 0.00
Epizyme (EPZM) United States $0.724B 0.00
AC Immune SA (ACIU) Switzerland $0.713B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.706B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.686B 0.00
Cellectis (CLLS) France $0.661B 0.00
Intra-Cellular Therapies (ITCI) United States $0.657B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.652B 0.00
Revance Therapeutics (RVNC) United States $0.647B 0.00
ANI Pharmaceuticals (ANIP) United States $0.627B 11.99
RA PHARMCTL INC (RARX) United States $0.627B 0.00
Intellia Therapeutics (NTLA) United States $0.615B 0.00
Twist Bioscience (TWST) United States $0.610B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.609B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.604B 0.00
Cara Therapeutics (CARA) United States $0.603B 0.00
Kura Oncology (KURA) United States $0.588B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.586B 0.00
Viking Therapeutics (VKTX) United States $0.580B 0.00
Arvinas (ARVN) United States $0.531B 0.00
UNITY Biotechnology (UBX) $0.515B 0.00
Anika Therapeutics (ANIK) United States $0.506B 20.93
Zymeworks (ZYME) Canada $0.505B 0.00
ObsEva SA (OBSV) Switzerland $0.486B 0.00
Osiris Therapeutics (OSIR) United States $0.483B 0.00
Inovio Pharmaceuticals (INO) United States $0.477B 0.00
Eidos Therapeutics (EIDX) United States $0.467B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.465B 0.00
Prothena (PRTA) Ireland $0.462B 0.00
Zealand Pharma (ZEAL) Denmark $0.454B 5.01
PDL BioPharma (PDLI) United States $0.445B 7.26
Mesoblast (MESO) Australia $0.442B 0.00
Arcus Biosciences (RCUS) United States $0.428B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.428B 0.00
Agenus (AGEN) United States $0.427B 0.00
Gritstone Oncology (GRTS) United States $0.423B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.423B 0.00
Synthorx (THOR) United States $0.411B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United Kingdom $0.403B 0.00
BeyondSpring (BYSI) United States $0.395B 0.00
DBV Technologies (DBVT) France $0.391B 0.00
Five Prime Therapeutics (FPRX) United States $0.388B 0.00
MediciNova (MNOV) United States $0.382B 0.00
Kezar Life Sciences (KZR) United States $0.379B 0.00
Senesco Technologies (ELOX) United States $0.373B 0.00
Scholar Rock Holding (SRRK) United States $0.371B 0.00
Sinovac Biotech (SVA) China $0.371B 0.00
Cytokineticsorporated (CYTK) United States $0.367B 0.00
Cellular Biomedicine (CBMG) United States $0.344B 0.00
Kindred Biosciences (KIN) United States $0.343B 0.00
Stemline Therapeutics (STML) United States $0.337B 0.00
Replimune (REPL) United States $0.334B 0.00
Abeona Therapeutics (ABEO) United States $0.330B 0.00
AVROBIO (AVRO) United States $0.323B 0.00
Krystal Biotech (KRYS) United States $0.319B 0.00
Evelo Biosciences (EVLO) United States $0.307B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.302B 0.00
Kodiak Sciences (KOD) United States $0.302B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.294B 0.00
Enochian Biosciences (ENOB) United States $0.293B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.292B 0.00
BioDelivery Sciences (BDSI) United States $0.290B 0.00
Albireo Pharma (ALBO) United States $0.288B 0.00
Merus (MRUS) Netherlands $0.280B 0.00
Urovant Sciences (UROV) United States $0.274B 0.00
MeiraGTx Holdings (MGTX) United States $0.273B 0.00
Sorrento Therapeutics (SRNE) United States $0.263B 0.00
Gamida Cell (GMDA) Israel $0.259B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.258B 0.00
Kadmon Holdings (KDMN) United States $0.257B 0.00
Axsome Therapeutics (AXSM) United States $0.254B 0.00
Intec Pharma (NTEC) Israel $0.245B 0.00
Verastem (VSTM) United States $0.243B 0.00
Celcuity (CELC) United States $0.241B 0.00
ResTORbio (TORC) United States $0.233B 0.00
Syros Pharmaceuticals (SYRS) United States $0.233B 0.00
Seres Therapeutics (MCRB) United States $0.231B 0.00
Magenta Therapeutics (MGTA) United States $0.229B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.228B 0.00
MannKind (MNKD) United States $0.223B 0.00
Sutro Biopharma (STRO) United States $0.223B 0.00
Strongbridge Biopharma (SBBP) United States $0.219B 0.00
Celyad SA (CYAD) Belgium $0.219B 0.00
Liquidia Technologies (LQDA) United States $0.217B 0.00
PSivida (EYPT) United States $0.215B 0.00
Aduro Biotech (ADRO) United States $0.215B 0.00
Kamada (KMDA) Israel $0.212B 19.52
Cerecor (CERC) United States $0.211B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.210B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.209B 0.00
XBiotech (XBIT) United States $0.208B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.202B 0.00
Equillium (EQ) United States $0.200B 0.00
Adverum Biotechnologies (ADVM) United States $0.197B 0.00
Athersys (ATHX) United States $0.197B 0.00
Arbutus Biopharma (ABUS) Canada $0.196B 0.00
CorMedix Inc (CRMD) United States $0.196B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.196B 0.00
Protagonist Therapeutics (PTGX) United States $0.193B 0.00
Aptinyx (APTX) United States $0.192B 0.00
Geron (GERN) United States $0.190B 0.00
Kala Pharmaceuticals (KALA) United States $0.187B 0.00
Compugen (CGEN) Israel $0.183B 0.00
Synlogic (SYBX) United States $0.180B 0.00
Enzo Biochem (ENZ) United States $0.177B 0.00
ChromaDex (CDXC) United States $0.176B 0.00
LogicBio Therapeutics (LOGC) United States $0.176B 0.00
TOCAGEN INC (TOCA) United States $0.174B 0.00
Allena Pharmaceuticals (ALNA) United States $0.173B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.172B 0.00
VBI Vaccines (VBIV) United States $0.164B 0.00
Constellation Pharmaceuticals (CNST) United States $0.164B 0.00
ADMA Biologics Inc (ADMA) United States $0.158B 0.00
Cohbar (CWBR) United States $0.153B 0.00
Motif Bio Plc (MTFB) United States $0.148B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.144B 0.00
Palatin Technologies (PTN) United States $0.144B 17.75
Erytech Pharma SA Sponsored ADR (ERYP) France $0.143B 0.00
Spero Therapeutics (SPRO) United States $0.143B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.136B 0.00
Menlo Therapeutics (MNLO) United States $0.133B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.131B 0.00
OvaScience (MLND) United States $0.130B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.129B 0.00
Pluristem Therapeutics (PSTI) Israel $0.129B 0.00
Unum Therapeutics (UMRX) United States $0.121B 0.00
BioTime (BTX) United States $0.119B 0.00
Axovant Sciences (AXON) United Kingdom $0.117B 0.00
Cue Biopharma (CUE) United States $0.115B 0.00
Organovo Holdings (ONVO) United States $0.114B 0.00
Pfenex (PFNX) United States $0.114B 0.00
VTv Therapeutics (VTVT) United States $0.111B 0.00
XOMA (XOMA) United States $0.110B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.110B 0.00
Checkpoint Therapeutics (CKPT) United States $0.109B 0.00
ETON PHARMACEUT (ETON) United States $0.107B 0.00
Proteostasis Therapeutics (PTI) United States $0.107B 0.00
NantKwest (NK) United States $0.102B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.101B 0.00
Neothetics (EVFM) United States $0.099B 0.00
Cocrystal Pharma (COCP) United States $0.097B 108.33
Catalyst Biosciences (CBIO) United States $0.096B 0.00
Signal Genetics (MGEN) United States $0.093B 0.00
Chiasma (CHMA) United States $0.092B 0.00
BioXcel Therapeutics (BTAI) United States $0.090B 0.00
PHASEBIO PHARMA (PHAS) United States $0.089B 0.00
VolitionRX (VNRX) Singapore $0.089B 0.00
OVID THERAPEUTC (OVID) United States $0.086B 0.00
ITUS (ANIX) United States $0.085B 0.00
Mersana Therapeutics (MRSN) United States $0.083B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.082B 0.00
Mustang Bio (MBIO) United States $0.082B 0.00
Cidara Therapeutics (CDTX) United States $0.082B 0.00
TIZIANA LIFE SC (TLSA) United Kingdom $0.081B 0.00
Provention Bio (PRVB) United States $0.081B 0.00
Aptose Biosciences (APTO) Canada $0.081B 0.00
Anavex Life Sciences (AVXL) United States $0.080B 0.00
Cel-Sci (CVM) United States $0.078B 0.00
Orgenesis (ORGS) United States $0.078B 0.00
Idera Pharmaceuticals (IDRA) United States $0.074B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.071B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.070B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.068B 0.00
ScPharmaceuticals (SCPH) United States $0.067B 0.00
Protalix BioTherapeutics (PLX) Israel $0.065B 0.00
Vaccinex (VCNX) United States $0.060B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.060B 0.00
Prima BioMed (IMMP) Australia $0.059B 0.00
AEterna Zentaris (AEZS) United States $0.059B 11.22
Fortress Biotech (FBIO) United States $0.059B 0.00
Alimera Sciences (ALIM) United States $0.059B 0.00
Oncobiologics (OTLK) United States $0.058B 0.00
Monster Digital (INNT) United States $0.058B 0.00
Eleven Biotherapeutics (SESN) United States $0.057B 0.00
Evogene (EVGN) Israel $0.056B 0.00
Celldex Therapeutics (CLDX) United States $0.056B 0.00
Ophthotech (OPHT) United States $0.055B 0.00
Applied Genetic Technologies (AGTC) United States $0.054B 0.00
Alcobra (ARCT) United States $0.053B 0.00
Bellerophon Therapeutics (BLPH) United States $0.052B 0.00
NewLink Genetics (NLNK) United States $0.051B 0.00
Proteon Therapeutics (PRTO) United States $0.050B 0.00
VistaGen Therapeutics (VTGN) United States $0.049B 0.00
Caladrius Biosciences (CLBS) United States $0.046B 0.00
Arsanis (ASNS) United States $0.045B 0.00
Bionano Genomics (BNGO) United States $0.045B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.044B 0.00
OncoSec Medical (ONCS) United States $0.044B 0.00
Trevena (TRVN) United States $0.044B 0.00
VIVUS (VVUS) United States $0.044B 0.00
Celsion (CLSN) United States $0.043B 0.00
DiaMedica Therapeutics (DMAC) United States $0.043B 0.00
Selecta Biosciences (SELB) United States $0.043B 0.00
Vascular Biogenics (VBLT) Israel $0.042B 0.00
AZURRX BIOPHARM (AZRX) United States $0.042B 0.00
Versartis (ARAV) United States $0.040B 3.54
Leap Therapeutics (LPTX) United States $0.040B 0.00
Entera Bio (ENTX) Israel $0.040B 0.00
Asterias Biotherapeutics (AST) United States $0.040B 0.00
Adial Pharmaceuticals (ADIL) United States $0.038B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.038B 0.00
Moleculin Biotech (MBRX) United States $0.037B 0.00
Clearside Biomedical (CLSD) United States $0.036B 0.00
Curis (CRIS) United States $0.035B 0.00
Sophiris Bio (SPHS) United States $0.035B 0.00
Oncolytics Biotech (ONCY) Canada $0.034B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.034B 0.00
AquaBounty Technologies (AQB) United States $0.034B 0.00
Aptevo Therapeutics (APVO) United States $0.034B 0.00
TRACON Pharmaceuticals (TCON) United States $0.031B 0.00
Galena Biopharma (SLS) United States $0.031B 0.00
Eyenovia (EYEN) United States $0.029B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.029B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.029B 4.69
Oragenics (OGEN) United States $0.027B 0.00
Zosano Pharma (ZSAN) United States $0.026B 0.00
IMMURON LTD (IMRN) Australia $0.025B 0.00
Advaxis (ADXS) United States $0.024B 0.00
GENPREX INC (GNPX) United States $0.024B 0.00
BioPharmX (BPMX) United States $0.024B 0.00
GTx (GTXI) United States $0.022B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.020B 0.00
Vical (VICL) United States $0.020B 0.00
CytRx (CYTR) United States $0.020B 0.00
Fibrocell Science Inc (FCSC) United States $0.019B 0.00
Novelion Therapeutics (NVLN) Canada $0.018B 0.00
Titan Pharmaceuticals (TTNP) United States $0.017B 0.00
Soligenix (SNGX) United States $0.017B 0.00
Cleveland BioLabs (CBLI) United States $0.017B 0.00
ATyr Pharma (LIFE) United States $0.016B 0.00
IBio (IBIO) United States $0.016B 0.00
Aileron Therapeutics (ALRN) United States $0.016B 0.00
Cellect Biotechnology (APOP) Israel $0.015B 0.00
Gemphire Therapeutics (GEMP) United States $0.015B 0.00
Novogen (KZIA) Australia $0.014B 0.00
TrovaGene (TROV) United States $0.014B 0.00
Prana Biotechnology (PRAN) Australia $0.014B 0.00
Genetic Technologies (GENE) Australia $0.014B 0.00
Therapix Biosciences (TRPX) Israel $0.013B 6.58
MYOS RENS Technology (MYOS) United States $0.012B 0.00
Edge Therapeutics (EDGE) United States $0.012B 0.00
Alliqua BioMedical (ALQA) United States $0.012B 0.00
Pulmatrix (PULM) United States $0.011B 0.00
Hemispherx BioPharma (HEB) United States $0.011B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.009B 0.00
Dare Bioscience (DARE) United States $0.009B 0.00
Aytu Bioscience (AYTU) United States $0.009B 0.00
Histogenics (HSGX) United States $0.009B 0.00
Vital Therapies (VTL) United States $0.009B 0.00
Synthetic Biologics (SYN) United States $0.009B 0.00
AmpliPhi Biosciences (APHB) United States $0.008B 0.00
RestorGenex (DFFN) United States $0.007B 0.00
Neuralstem (CUR) United States $0.007B 0.00
Stellar Biotechnologies (SBOT) United States $0.006B 0.00
ARCA Biopharma (ABIO) United States $0.006B 0.00
Flex Pharma (FLKS) United States $0.006B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.005B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.005B 0.00
Tenax Therapeutics (TENX) United States $0.002B 0.00
Bio-Rad Laboratories (BIO.B) United States $0.000B 0.00
OSMOTICA PHARM (OSMT) United States $0.000B 0.00